KMDA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Kamada

NASDAQ | KMDA

6.82

USD

$0.00

(

0.00%

)

At Close (As of Oct 30, 2025)

$401.92M

Market Cap

21.62

P/E Ratio

0.32

EPS

$8.90

52 Week High

$5.50

52 Week Low

HEALTHCARE

Sector

KMDA Chart

Recent Chart
Price Action

KMDA Technicals

Tags:

KMDA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $70M
Total Revenue $161M
Cost Of Revenue $91M
Costof Goods And Services Sold $91M
Operating Income $20M
Selling General And Administrative $20M
Research And Development $15M
Operating Expenses $50M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $2.1M
Interest Expense $660K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax $13M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations $14M
Comprehensive Income Net Of Tax -
Ebit $14M
Ebitda $28M
Net Income $14M

Revenue & Profitability

Earnings Performance

KMDA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $372M
Total Current Assets $184M
Cash And Cash Equivalents At Carrying Value $78M
Cash And Short Term Investments $78M
Inventory $79M
Current Net Receivables $23M
Total Non Current Assets $188M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $102M
Intangible Assets Excluding Goodwill $102M
Goodwill $30M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $3.9M
Other Non Current Assets -
Total Liabilities $113M
Total Current Liabilities $49M
Current Accounts Payable $28M
Deferred Revenue -
Current Debt -
Short Term Debt $1.6M
Total Non Current Liabilities $63M
Capital Lease Obligations $11M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $11M
Other Current Liabilities $20M
Other Non Current Liabilities $53M
Total Shareholder Equity $259M
Treasury Stock -
Retained Earnings -$26M
Common Stock $15M
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $48M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $14M
Capital Expenditures $11M
Change In Receivables -
Change In Inventory $9.7M
Profit Loss -
Cashflow From Investment -$11M
Cashflow From Financing -$14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $14M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $70M
Total Revenue $161M
Cost Of Revenue $91M
Costof Goods And Services Sold $91M
Operating Income $20M
Selling General And Administrative $20M
Research And Development $15M
Operating Expenses $50M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $2.1M
Interest Expense $660K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax $13M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations $14M
Comprehensive Income Net Of Tax -
Ebit $14M
Ebitda $28M
Net Income $14M

Dividends

Field Value
Ex Dividend Date 2025-03-17
Declaration Date 2025-03-11
Record Date 2025-03-17
Payment Date 2025-04-07
Amount 0.2

KMDA News

KMDA Profile

Kamada Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Kamada Ltd. is a biopharmaceutical company based in Rehovot, Israel, specializing in the development and commercialization of plasma-derived protein therapies for rare diseases. The company has established a robust pipeline targeting significant unmet medical needs, leveraging its proprietary technology to yield high-quality therapeutic solutions. With a strong commitment to innovation and a strategic focus on advancing patient care, Kamada presents a compelling investment opportunity in the biotechnology sector, particularly for institutional investors seeking exposure to high-growth healthcare markets. As it continues to navigate the evolving landscape of biopharmaceuticals, Kamada is well-positioned for sustained success.

INTS
+394.56%
$1.32
VHAI
0.00%
$0.00
BYND
-10.56%
$1.65
YDKG
-11.47%
$0.04
ABEV
+5.50%
$2.29
IXHL
+17.77%
$0.40
CMG
-18.18%
$32.53
MSAI
+30.69%
$1.32
NOK
-2.72%
$7.13
WTO
-10.72%
$0.04
JZXN
+18.07%
$0.32
INTC
-2.85%
$40.15
PLUG
-3.98%
$2.65
F
-1.35%
$13.06
GOOGL
+2.51%
$281.48
TSLA
-4.63%
$440.10
BTG
+2.09%
$4.87
GETY
+42.28%
$2.86
AAPL
+0.63%
$271.39
GPUS
-2.46%
$0.43
BITF
-4.69%
$4.05
AXDX
-61.36%
$0.03
RGTI
+7.89%
$42.52
FI
-7.66%
$65.19
BURU
-3.12%
$0.33
ORIS
+17.11%
$0.16
ADAP
-15.14%
$0.05
CLF
-12.98%
$12.26
GOOG
+2.44%
$281.89
NLSP
+2.97%
$0.76
CORZ
-0.14%
$20.74
FMC
-46.52%
$15.53
TV
-2.54%
$2.68
CERO
-94.68%
$0.09
BENF
+21.27%
$0.67
ADTX
-8.82%
$0.06
PLTR
-2.14%
$194.55
LUMN
-6.00%
$10.34
AMZN
+11.77%
$249.09
BMNR
-10.47%
$44.55
RIVN
-5.25%
$12.99
RMBL
+60.50%
$3.21
GRAB
-1.15%
$5.98
HPE
+0.57%
$24.41
VALE
+0.50%
$11.89
LAES
+9.19%
$6.89
ADD
-25.47%
$0.05
METU
-22.78%
$34.04
BAC
+0.85%
$53.03
KMX
-1.38%
$41.87
NIO
-1.82%
$7.01
PFSA
-9.85%
$0.25
AMCR
-1.87%
$7.85
SRM
+53.27%
$10.30
CJET
-14.18%
$0.04
AMC
-4.51%
$2.54
AZTR
+18.52%
$0.59
AGNC
-0.59%
$10.00
WLGS
-5.57%
$0.04
ORCL
-6.68%
$256.89
EPWK
-1.78%
$0.06
UUUU
+6.96%
$21.82
CRML
+11.13%
$12.88
ADVB
+24.55%
$0.56
JOBY
-2.81%
$16.55
KDLY
-9.97%
$0.85
ETWO
0.00%
$3.30
AVTR
-4.57%
$11.05
STLA
-9.54%
$10.14
MO
-7.81%
$57.13
APLD
-1.36%
$33.95
AVGO
-2.46%
$376.47
PBR
-1.34%
$11.72
AFMD
-34.94%
$0.18
NVTS
-7.44%
$12.56
CCL
+1.65%
$28.33
FUBO
-0.81%
$3.66
NIVF
-22.44%
$0.83
KDP
+1.95%
$27.68
NVO
-2.58%
$50.04
RIOT
-4.87%
$21.09
OPI
-16.97%
$0.20
PLTD
+2.28%
$6.28
KLG
-9.05%
$13.35
VIAV
+22.31%
$17.10
CGC
-2.40%
$1.22
HOOD
-4.64%
$138.07
GRYP
-10.38%
$1.38
CRWV
-6.33%
$131.06
RR
-2.36%
$4.95
LMFA
+9.01%
$1.09
MODV
-25.22%
$0.43
NVDA
+1.86%
$206.66
SBUX
-1.21%
$83.15
AGL
-7.36%
$0.80
CSCO
+2.21%
$72.91
BE
-4.38%
$127.85
NXPL
+16.40%
$0.98
SMCI
-4.40%
$50.37
FSM
+2.86%
$8.26
INTS
+394.56%
$1.32
VHAI
0.00%
$0.00
BYND
-10.56%
$1.65
YDKG
-11.47%
$0.04
ABEV
+5.50%
$2.29
IXHL
+17.77%
$0.40
CMG
-18.18%
$32.53
MSAI
+30.69%
$1.32
NOK
-2.72%
$7.13
WTO
-10.72%
$0.04
JZXN
+18.07%
$0.32
INTC
-2.85%
$40.15
PLUG
-3.98%
$2.65
F
-1.35%
$13.06
GOOGL
+2.51%
$281.48
TSLA
-4.63%
$440.10
BTG
+2.09%
$4.87
GETY
+42.28%
$2.86
AAPL
+0.63%
$271.39
GPUS
-2.46%
$0.43
BITF
-4.69%
$4.05
AXDX
-61.36%
$0.03
RGTI
+7.89%
$42.52
FI
-7.66%
$65.19
BURU
-3.12%
$0.33
ORIS
+17.11%
$0.16
ADAP
-15.14%
$0.05
CLF
-12.98%
$12.26
GOOG
+2.44%
$281.89
NLSP
+2.97%
$0.76
CORZ
-0.14%
$20.74
FMC
-46.52%
$15.53
TV
-2.54%
$2.68
CERO
-94.68%
$0.09
BENF
+21.27%
$0.67
ADTX
-8.82%
$0.06
PLTR
-2.14%
$194.55
LUMN
-6.00%
$10.34
AMZN
+11.77%
$249.09
BMNR
-10.47%
$44.55
RIVN
-5.25%
$12.99
RMBL
+60.50%
$3.21
GRAB
-1.15%
$5.98
HPE
+0.57%
$24.41
VALE
+0.50%
$11.89
LAES
+9.19%
$6.89
ADD
-25.47%
$0.05
METU
-22.78%
$34.04
BAC
+0.85%
$53.03
KMX
-1.38%
$41.87
NIO
-1.82%
$7.01
PFSA
-9.85%
$0.25
AMCR
-1.87%
$7.85
SRM
+53.27%
$10.30
CJET
-14.18%
$0.04
AMC
-4.51%
$2.54
AZTR
+18.52%
$0.59
AGNC
-0.59%
$10.00
WLGS
-5.57%
$0.04
ORCL
-6.68%
$256.89
EPWK
-1.78%
$0.06
UUUU
+6.96%
$21.82
CRML
+11.13%
$12.88
ADVB
+24.55%
$0.56
JOBY
-2.81%
$16.55
KDLY
-9.97%
$0.85
ETWO
0.00%
$3.30
AVTR
-4.57%
$11.05
STLA
-9.54%
$10.14
MO
-7.81%
$57.13
APLD
-1.36%
$33.95
AVGO
-2.46%
$376.47
PBR
-1.34%
$11.72
AFMD
-34.94%
$0.18
NVTS
-7.44%
$12.56
CCL
+1.65%
$28.33
FUBO
-0.81%
$3.66
NIVF
-22.44%
$0.83
KDP
+1.95%
$27.68
NVO
-2.58%
$50.04
RIOT
-4.87%
$21.09
OPI
-16.97%
$0.20
PLTD
+2.28%
$6.28
KLG
-9.05%
$13.35
VIAV
+22.31%
$17.10
CGC
-2.40%
$1.22
HOOD
-4.64%
$138.07
GRYP
-10.38%
$1.38
CRWV
-6.33%
$131.06
RR
-2.36%
$4.95
LMFA
+9.01%
$1.09
MODV
-25.22%
$0.43
NVDA
+1.86%
$206.66
SBUX
-1.21%
$83.15
AGL
-7.36%
$0.80
CSCO
+2.21%
$72.91
BE
-4.38%
$127.85
NXPL
+16.40%
$0.98
SMCI
-4.40%
$50.37
FSM
+2.86%
$8.26
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.